SCHEMBL2911588

SCHEMBL2911588

Cc1ccc(-c2cn(CCCNc3ccc([N+](=O)[O-])c(N)n3)cc2C(=O)NC[C@H](C)O)cc1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 1/20 0.34
GSK3B P49841 2/20 0.34
GSK3A P49840 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
LMNA P02545 3/20 0.32
S1PR4 O95977 1/20 0.32
ADRB2 P07550 1/20 0.32
MAPT P10636 1/20 0.32
S1PR1 P21453 1/20 0.32
NOD2 Q9HC29 1/20 0.32
CYP19A1 P11511 1/20 0.32
AXL P30530 2/20 0.32
MERTK Q12866 2/20 0.32
HPGD P15428 1/20 0.32
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2911036 1.00 ALDH1A1 (0.34) ALDH1A1KDM4EGSK3BGSK3ASMN1; SMN2
SCHEMBL2938731 0.93 MET (0.34) ALDH1A1GSK3BGSK3ASMN1; SMN2LMNA
SCHEMBL2912251 0.93 SMN1; SMN2 (0.40) ALDH1A1GSK3BGSK3ASMN1; SMN2LMNA
SCHEMBL2907242 0.93 LMNA (0.34) ALDH1A1GSK3BGSK3ASMN1; SMN2LMNA
SCHEMBL2904193 0.93 SMN1; SMN2 (0.40) ALDH1A1GSK3BGSK3ASMN1; SMN2LMNA
SCHEMBL2908179 0.93 MET (0.34) ALDH1A1GSK3BGSK3ASMN1; SMN2LMNA
SCHEMBL2904632 0.93 LMNA (0.34) ALDH1A1GSK3BGSK3ASMN1; SMN2LMNA
SCHEMBL2911017 0.92 GSK3B (0.33) ALDH1A1GSK3BGSK3ASMN1; SMN2ADORA2A
SCHEMBL2911391 0.92 GSK3B (0.33) ALDH1A1GSK3BGSK3ASMN1; SMN2ADORA2A
SCHEMBL2907828 0.92 HPGD (0.36) ALDH1A1GSK3BGSK3ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed